Raras
Buscar doenças, sintomas, genes...
Esclerite infecciosa
ORPHA:648665CID-10 · H15.0CID-11 · 9B51DOENÇA RARA

Artrite reumatoide é uma doença autoimune de longa duração que provoca dor e inflamação nas articulações sinoviais. A dor e rigidez muitas vezes agravam-se a seguir ao descanso. É mais comum nas articulações do pulso e das mãos, afetando geralmente as mesmas articulações dos dois lados do corpo. A doença pode também afetar outras partes do corpo e causar diminuição do número de glóbulos vermelhos, inflamação à volta dos pulmões e inflamação à volta do coração. Pode também verificar-se febre e falta de energia. Muitas vezes os sintomas começam-se a manifestar gradualmente ao longo de semanas ou meses.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

Inflamação grave da esclera, frequentemente causada por bactérias, fungos ou vírus, levando a dor intensa, vermelhidão e possível perda visual. O diagnóstico precoce e tratamento agressivo com antibióticos ou antifúngicos são cruciais.

Publicações científicas
151 artigos
Último publicado: 2026 Jun
🏥
SUS: Sem cobertura SUSScore: 0%
CID-10: H15.0
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico151PubMed
Últimos 10 anos90publicações
Pico202215 papers
Linha do tempo
2026Hoje · 2026🧪 2003Primeiro ensaio clínico📈 2022Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

🧬

Nenhum gene associado encontrado

Os dados genéticos desta condição ainda estão sendo catalogados.

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
1Fase 11
Medicamentos catalogadosEnsaios clínicos· 0 medicamentos · 1 ensaio
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Esclerite infecciosa

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Pesquisa e ensaios clínicos

1 ensaios clínicos encontrados.

Distribuição por fase
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
94 papers (10 anos)
#1

Systemic immunosuppressive therapy in idiopathic non-infectious uveitis and scleritis: disease remission, discontinuation, and relapse patterns.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie2026 Apr

Immunosuppressive therapy (IST) is indicated in idiopathic non-infectious uveitis and scleritis when local or topical treatments are insufficient, but long-term outcomes and predictors of relapse remain incompletely defined. We retrospectively reviewed clinical records of 110 patients with non-infectious uveitis or scleritis in the absence of systemic manifestation of disease who received IST. Time to remission, treatment duration, and relapse after IST withdrawal were analyzed by anatomic subtype. Predictors of remission and relapse were assessed using multivariable Cox and logistic regression models. Median follow-up was 84 months (IQR 48-135). Most patients achieved remission with first-line IST (79%), Methotrexate predominated in anterior (n = 27, 90%), intermediate (n = 13, 93%), and scleritis (n = 11, 85%), whereas cyclosporine was preferred in posterior (n = 20, 65%) and panuveitis (n = 12, 54%). Biological therapy (adalimumab) was used infrequently (n = 8, 7%). Median time to remission was 7 months (IQR 3.1-12.5), although posterior uveitis required significantly longer to remit (median 11 months; HR = 0.45 vs. AU, p = 0.005). Need for concomitant low-dose corticosteroids (≤10 mg/day) to achieve remission was associated with delayed remission (HR = 0.55, p = 0.006). IST was discontinued in 47% of patients, most commonly after ≥ 2 years due to disease control, while early discontinuation (< 2 years) was primarily due to adverse effects. Relapse occurred in 27% after withdrawal, typically within 10 months. Univariate analysis suggested differences by subtype, but only longer time to remission (p = 0.018) and shorter IST duration (p < 0.05) independently predicted relapse in multivariable models. IST effectively induced remission and reduced relapse rates in ocular-only non-infectious inflammation. Achieving early control (within six months) and maintaining IST for at least two years were associated with more durable remission. Posterior involvement and the need for concomitant low-dose oral corticosteroids reflected greater disease severity, whereas delayed remission and shorter IST duration independently predicted relapse.

#2

Chronic necrotizing sclerouveitis caused by Alternaria doliconidium.

European journal of ophthalmology2026 Jan

PurposeTo report a case of fungal sclerouveitis caused by Alternaria doliconidium, misdiagnosed as autoimmune scleritis and incorrectly treated with immunosuppressive therapy.ObservationsA 69-year-old man presented with progressive chronic necrotizing scleritis in his right eye following ocular trauma. Initial treatment with antimicrobial and steroid therapy showed no improvement, and a scleral biopsy yielded inconclusive results. Autoimmune scleritis was suspected, leading to treatment with systemic steroids and immunosuppressants. Upon further examination, nodular necrotizing scleritis with scleral translucency and whitish floccules in the anterior chamber was observed, prompting a suspicion of fungal etiology. Molecular analysis via PCR confirmed the presence of Alternaria doliconidium.Conclusions and ImportanceThis case underscores the importance of considering fungal pathogens in cases unresponsive to conventional treatment and the critical role of advanced molecular diagnostics. This is the first reported case of sclerouveitis caused by Alternaria doliconidium, expanding the spectrum of ocular infections associated with this genus.

#3

Long-Term Outcomes of 4-Point Expanded Polytetrafluoroethylene and 2-Point Polypropylene Fixation of Scleral-Sutured Intraocular Lenses.

Journal of vitreoretinal diseases2025 Dec 30

Purpose: To compare the long-term outcomes of scleral-sutured intraocular lens (IOL) fixation using expanded polytetrafluoroethylene vs polypropylene sutures, with a focus on suture-related complications. Methods: A retrospective comparative review was conducted of 102 patients who underwent scleral-sutured IOL fixation between 2015 and 2019. Forty-eight eyes of 48 patients received 4-point fixation with expanded polytetrafluoroethylene sutures, and 55 eyes of 54 patients received 2-point fixation with polypropylene sutures. Postoperative complications, visual outcomes, and risk factors for suture-related complications were analyzed over a minimum follow-up of 5 years. Results: No instances of suture breakage were observed in either group over an average follow-up of 6.7 years. Suture exposure rates were 10.4% (5/48) for expanded polytetrafluoroethylene and 18.2% (10/55) for polypropylene (P = .27). The mean time to suture exposure was 2.7 ± 3.3 years in the expanded polytetrafluoroethylene group and 2.9 ± 2.5 years in the polypropylene group (P = .88). Mean logMAR visual acuity at final follow-up was 1.0 ± 1.2 in the expanded polytetrafluoroethylene group and 1.5 ± 1.2 in the polypropylene group (P = .06). The only significant risk factor for suture exposure was concurrent corneal transplantation or glaucoma surgery (odds ratio [OR], 9.3; P = .003). Surgical correction was required in all cases of exposure with expanded polytetrafluoroethylene sutures and in 2 cases with polypropylene sutures. One case of suture-associated infectious scleritis with endophthalmitis occurred in the expanded polytetrafluoroethylene group, and 1 case of endophthalmitis related to an explanted corneal graft occurred in the polypropylene group. Conclusions: Both expanded polytetrafluoroethylene and polypropylene sutures demonstrated durable outcomes with similar complication rates. Suture breakage was not observed in either group, and there were no differences in suture exposure rates between the 2 groups. Risk factors for suture exposure included the performance of a concurrent procedure.

#4

Scleritis Secondary to Eosinophilic Granulomatosis With Polyangiitis.

Journal of vitreoretinal diseases2025 Oct 25

Purpose: To describe a case of severe scleritis with uveitis as the initial presentation of underlying eosinophilic granulomatosis with polyangiitis. Methods: Case report from a university ophthalmology clinic describing ocular findings, diagnostic workup, and treatment for a 75-year-old woman presenting with severe anterior scleritis and panuveitis. Results: The patient was initially misdiagnosed and treated for presumed infectious scleritis for 1 month without improvement. Further workup revealed elevated perinuclear anti-neutrophil cytoplasmic antibodies, supporting a diagnosis of eosinophilic granulomatosis with polyangiitis. Prompt initiation of high-dose oral corticosteroids led to rapid resolution of ocular inflammation. Conclusions: Severe scleritis with uveitis can be the first manifestation of occult eosinophilic granulomatosis with polyangiitis. A high index of suspicion for underlying autoimmune disease and timely rheumatologic workup are essential for accurate diagnosis. Early systemic immunosuppressive therapy is critical to optimize visual outcomes and prevent irreversible ocular damage.

#5

A Rare Case of Pseudomonas aeruginosa Keratoscleritis: Highlighting Early Diagnosis and Aggressive Treatment.

Cureus2025 Sep

Pseudomonas aeruginosa keratoscleritis (PAK) is an uncommon but aggressive ocular infection that can rapidly threaten vision if not recognized and treated promptly. A 75‑year‑old woman presented with a large corneal epithelial defect, stromal infiltrates, and hypopyon. She was initially managed empirically for fungal keratitis but later diagnosed with PAK following scleral nodule excision and positive cultures for Pseudomonas aeruginosa (P. aeruginosa). Intensive therapy, including topical and systemic antibiotics, subconjunctival injections, and autologous serum tears, gradually improved corneal ulceration and scleritis. Although her visual acuity remained severely impaired, early initiation of targeted antimicrobial therapy preserved ocular integrity and avoided surgical intervention. PAK is a rare, sight-threatening infection with high morbidity if treatment is delayed. This case highlights the importance of early and accurate diagnosis, together with prompt and aggressive antimicrobial management to prevent complications and preserve the globe.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC61 artigos no totalmostrando 89

2026

Systemic immunosuppressive therapy in idiopathic non-infectious uveitis and scleritis: disease remission, discontinuation, and relapse patterns.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie
2025

Long-Term Outcomes of 4-Point Expanded Polytetrafluoroethylene and 2-Point Polypropylene Fixation of Scleral-Sutured Intraocular Lenses.

Journal of vitreoretinal diseases
2025

Scleritis Secondary to Eosinophilic Granulomatosis With Polyangiitis.

Journal of vitreoretinal diseases
2025

A Rare Case of Pseudomonas aeruginosa Keratoscleritis: Highlighting Early Diagnosis and Aggressive Treatment.

Cureus
2026

Chronic necrotizing sclerouveitis caused by Alternaria doliconidium.

European journal of ophthalmology
2025

Infectious scleritis: a comprehensive narrative review of epidemiology, clinical characteristics, and management strategies.

Therapeutic advances in ophthalmology
2025

Infectious Scleritis Masquerading as Isolated Orbital Cellulitis: A Case Report.

Cureus
2025

The sequential therapy for non-infectious scleritis: A case report.

SAGE open medical case reports
2025

Bacterial Infectious Scleritis: A Case Report.

Infection and drug resistance
2025

Infectious scleritis: a review of etiologies, clinical features, and management strategies.

Frontiers in ophthalmology
2025

Incidence and Outcome of Cataract in Eyes with Scleritis and Episcleritis.

Ocular immunology and inflammation
2025

Pseudomonas-induced scleritis mimicking autoimmune necrotizing scleritis. A case report.

Archivos de la Sociedad Espanola de Oftalmologia
2024

Ocular scedosporiosis: A case series.

American journal of ophthalmology case reports
2024

Efficacy and tolerability of subcutaneous repository corticotropin injection in refractory ocular inflammatory diseases.

Journal of ophthalmic inflammation and infection
2025

Limbal Subconjunctival Abscess: A Rare Complication of Acanthamoeba Keratitis.

Cornea
2025

Infectious Scleritis - Clinical Characteristics, Causative Factors, and Treatment Outcomes in an Indian Population.

Ocular immunology and inflammation
2024

Bacillus coagulans-associated severe necrotizing scleral infection.

American journal of ophthalmology case reports
2024

Aspergillus Endophthalmitis Secondary to Infectious Scleritis: Utility of Diagnostic PCR.

Retinal cases &amp; brief reports
2024

A Case of Incidental and Uncomplicated Subretinal Triamcinolone Acetonide.

Case reports in ophthalmology
2024

Subconjunctival Dirofilaria masquerading as nodular scleritis.

BMJ case reports
2024

The enigma of sclera-specific autoimmunity in scleritis.

Journal of autoimmunity
2024

Bilateral Scleritis with Heterogeneous Etiologies: A Diagnostic Dilemma.

Ocular immunology and inflammation
2023

Surgical induced necrotizing scleritis following intraocular lens replacement.

Journal of ophthalmic inflammation and infection
2024

Adalimumab in the treatment of refractory non-infectious scleritis: 6-month outcomes.

Eye (London, England)
2023

Fungal panophthalmitis presenting as severe posterior scleritis.

American journal of ophthalmology case reports
2024

Determinants of Clinical Outcomes After Infectious Scleritis.

Cornea
2024

Successful Management of Extensively Drug Resistant Pseudomonas aeruginosa-Infectious Scleritis after Pterygium Surgery.

Ocular immunology and inflammation
2024

Necrotizing Scleritis: A Review.

Ocular immunology and inflammation
2023

Moraxella nonliquefaciens-associated infectious scleritis.

BMJ case reports
2024

Therapeutic Outcomes of Non-Infectious Scleritis Treated with Tumor Necrosis Factor-Alpha Inhibitors.

Ocular immunology and inflammation
2023

Surgically induced scleral necrosis associated with concomitant tuberculosis infection: a diagnostic challenge.

GMS ophthalmology cases
2024

Glaucoma Surgical Outcomes in Patients with a History of Scleritis.

Ocular immunology and inflammation
2023

Etiology, Pathogens, Clinical Features and Treatment of Bacterial Scleritis.

Seminars in ophthalmology
2023

Subpalpebral Antibiotic Lavage for the Treatment of Refractory Infectious Scleritis.

Ophthalmic plastic and reconstructive surgery
2023

Nocardia arthritidis scleritis: A case report.

American journal of ophthalmology case reports
2022

Clinical features and long-term treatment outcome of posterior scleritis.

Annals of translational medicine
2022

Adalimumab plus Conventional Therapy versus Conventional Therapy in Refractory Non-Infectious Scleritis.

Journal of clinical medicine
2022

Baricitinib in severe and refractory peripheral ulcerative keratitis: a case report and literature review.

Therapeutic advances in musculoskeletal disease
2022

Successful control of scleritis caused by Nocardia farcinica: A case report.

Medicine
2022

A case of bilateral sclerouveitis with secondary glaucoma right eye.

Medical journal, Armed Forces India
2023

Role of anterior segment optical coherence tomography in scleral diseases: A review.

Seminars in ophthalmology
2022

Plasmapheresis as a viable treatment option for scleritis.

American journal of ophthalmology case reports
2022

A case of anterior scleritis in association with posterior scleritis - a diagnostic riddle.

GMS ophthalmology cases
2023

Possible Synergistic Role of Cryo-Alcohol Therapy in Infectious Scleritis-Scope and Rationale for Expanding Indications and Review of the Literature.

Cornea
2022

Subconjunctival Rituximab Administration for the Treatment of Scleritis.

Ocular immunology and inflammation
2022

Development and Implementation of the AIDA International Registry for Patients with Non-Infectious Scleritis.

Ophthalmology and therapy
2022

The Association Between Mental Health Disorders and Non-Infectious Scleritis: A Prevalence Study and Review of the Literature.

European journal of ophthalmology
2022

A novel technique of full-thickness scleral debridement in fulminant necrotising infectious scleritis and its outcomes-a consecutive case series.

International ophthalmology
2021

Biologic Therapies and Small Molecules for the Management of Non-Infectious Scleritis: A Narrative Review.

Ophthalmology and therapy
2022

Clinical Relevance of Autoantibodies and Inflammatory Parameters in Non-infectious Scleritis.

Ocular immunology and inflammation
2021

Preserved corneal lamellar transplantation for infectious and noninfectious scleral defects: Three case reports and literature review.

Medicine
2021

Rituximab for non-infectious Uveitis and Scleritis.

Journal of ophthalmic inflammation and infection
2021

Bilateral infectious scleritis from Histoplasma capsulatum in an immunosuppressed uveitis patient.

American journal of ophthalmology case reports
2022

Patterns of Non-Infectious Scleritis across a Tertiary Eye Care Network Using the Indigenously Developed Electronic Medical Record System-eyeSmart.

Ocular immunology and inflammation
2021

Infectious Scleritis: Pathophysiology, Diagnosis, and Management.

Eye &amp; contact lens
2022

Efficacy and maintenance of rituximab treatment in non-infectious scleritis.

Acta ophthalmologica
2021

Subconjunctival Dirofilariasis Mimicking Infectious Scleritis.

Journal of pediatric ophthalmology and strabismus
2022

Infectious Scleritis due to Methicillin-resistant Staphylococcus Aureus after Dengue Viral Fever.

Ocular immunology and inflammation
2021

Umbilical amnion and amniotic membrane transplantation for infectious scleritis and scleral melt: A case series.

American journal of ophthalmology case reports
2021

Recalcitrant infective scleritis masquerading an autoimmune necrotising scleritis: a primary presentation of biopsy-proven granulomatosis with polyangiitis.

BMJ case reports
2021

The clinical and pathogenic spectrum of surgically-induced scleral necrosis: A review.

Survey of ophthalmology
2020

Necrotising fungal scleritis with full-thickness scleral melt and circumferential progression: a novel debridement approach.

BMJ case reports
2020

The haplotypes of various TNF related genes associated with scleritis in Chinese Han.

Human genomics
2020

The Existence of Periodontal Disease and Subsequent Ocular Diseases: A Population-Based Cohort Study.

Medicina (Kaunas, Lithuania)
2020

Scleritis: Differentiating infectious from non-infectious entities.

Indian journal of ophthalmology
2021

Alternaria chartarum sclerokeratouveitis: A new fungus cause.

Taiwan journal of ophthalmology
2020

Effectiveness of TNF-α blockade in the treatment of refractory non-infectious scleritis: a multicentre study.

Clinical and experimental rheumatology
2020

Effectiveness of pharmacological agents for the treatment of non-infectious scleritis: a systematic review protocol.

Systematic reviews
2019

Tuberculous scleritis in a young Asian Indian girl-a case presentation and literature review.

Journal of ophthalmic inflammation and infection
2019

A case report of infectious scleritis with corneal ulcer caused by Scedosporium aurantiacum.

Medicine
2019

Histopathological evaluation of scleritis.

Journal of clinical pathology
2019

Pattern of Scleritis in an Egyptian Cohort.

Ocular immunology and inflammation
2018

Ocular Basidiobolomycosis: A Case Report.

Case reports in ophthalmology
2018

Infectious Scleritis: What the ID Clinician Should Know.

Open forum infectious diseases
2018

Combined Tenonplasty and Scleral Graft for Refractory Pseudomonas Scleritis Following Pterygium Removal with Mitomycin C Application.

Journal of ophthalmic &amp; vision research
2018

Iontophoretic delivery of dexamethasone phosphate for non-infectious, non-necrotising anterior scleritis, dose-finding clinical trial.

The British journal of ophthalmology
2018

Scedosporium apiospermum infectious scleritis following posterior subtenon triamcinolone acetonide injection: a case report and literature review.

BMC ophthalmology
2019

Interventions and Outcomes in Patients with Infectious Pseudomonas scleritis: A 10-Year Perspective.

Ocular immunology and inflammation
2017

Pseudomonas Scleritis following Pterygium Excision.

Case reports in ophthalmology
2017

[Scleritis and episcleritis].

Journal francais d'ophtalmologie
2016

Infectious Pseudomonas and Bipolaris scleritis following history of pterygium surgery.

Indian journal of ophthalmology
2017

Anterior infectious necrotizing scleritis secondary to Pseudomonas aeruginosa infection following intravitreal ranibizumab injection.

American journal of ophthalmology case reports
2016

Diagnosis and management of non-infectious immune-mediated scleritis: current status and future prospects.

Expert review of clinical immunology
2015

Clinical features and visual outcomes of scleritis patients presented to tertiary care eye centers in Saudi Arabia.

International journal of ophthalmology
2016

Conjunctival Sensation in Scleritis.

Ocular immunology and inflammation
2015

Successful Treatment of Infectious Scleritis by Pseudomonas aeruginosa with Autologous Perichondrium Graft of Conchal Cartilage.

Yonsei medical journal
2015

Risk factors and clinical outcomes of bacterial and fungal scleritis at a tertiary eye care hospital.

Middle East African journal of ophthalmology
2015

Nodular syphilitic scleritis masquerading as an ocular tumor.

Journal of ophthalmic inflammation and infection
2015

Experience of scleritis and episcleritis at a tertiary center in Southern Taiwan.

Taiwan journal of ophthalmology

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Esclerite infecciosa.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Esclerite infecciosa

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Ainda não achamos doenças com sintomas parecidos o suficiente.

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Systemic immunosuppressive therapy in idiopathic non-infectious uveitis and scleritis: disease remission, discontinuation, and relapse patterns.
    Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie· 2026· PMID 41498798mais citado
  2. Chronic necrotizing sclerouveitis caused by Alternaria doliconidium.
    European journal of ophthalmology· 2026· PMID 40956900mais citado
  3. Long-Term Outcomes of 4-Point Expanded Polytetrafluoroethylene and 2-Point Polypropylene Fixation of Scleral-Sutured Intraocular Lenses.
    Journal of vitreoretinal diseases· 2025· PMID 41479849mais citado
  4. Scleritis Secondary to Eosinophilic Granulomatosis With Polyangiitis.
    Journal of vitreoretinal diseases· 2025· PMID 41146906mais citado
  5. A Rare Case of Pseudomonas aeruginosa Keratoscleritis: Highlighting Early Diagnosis and Aggressive Treatment.
    Cureus· 2025· PMID 41098295mais citado
  6. Rhizopus angle abscess, scleritis and endophthalmitis following Kahook Dual Blade goniotomy and phacoemulsification.
    Am J Ophthalmol Case Rep· 2026· PMID 41939082recente
  7. Update on Therapy for Non-Infectious Scleritis.
    Clin Ophthalmol· 2026· PMID 41937961recente
  8. Is Methotrexate a Superior Alternative to Steroids or Placebo for Scleritis? A Systematic Review and Meta-Analysis on Efficacy and Safety.
    J Ocul Pharmacol Ther· 2026· PMID 41931384recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:648665(Orphanet)
  2. MONDO:0958264(MONDO)
  3. Busca completa no PubMed(PubMed)
  4. Artigo Wikipedia(Wikipedia)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Esclerite infecciosa
Compêndio · Raras BR

Esclerite infecciosa

ORPHA:648665 · MONDO:0958264
CID-10
H15.0 · Esclerite
CID-11
MedGen
UMLS
C5816746
EuropePMC
Wikipedia
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades